Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease: A retrospective study

Jihad Mallat, Fadi Hamed, Maher Balkis, Mohamed A. Mohamed, Mohamad Mooty, Asim Malik, Ahmad Nusair, Maria-Fernanda Bonilla
doi: https://doi.org/10.1101/2020.04.27.20082180

Article usage

Article usage: May 2020 to November 2024

AbstractFullPdf
May 2020660701167
Jun 20208610312
Jul 20205720193
Aug 20204160119
Sep 2020242058
Oct 2020178044
Nov 2020163039
Dec 2020130246
Jan 2021197639
Feb 2021236334
Mar 20211921820
Apr 2021167412
May 2021173732
Jun 2021125222
Jul 202175422
Aug 2021961120
Sep 202167722
Oct 202194236
Nov 202196329
Dec 20216509
Jan 202284716
Feb 202253813
Mar 202267315
Apr 20224457
May 202274018
Jun 20224329
Jul 20223628
Aug 202238212
Sep 202254319
Oct 202248112
Nov 202230115
Dec 20222617
Jan 20232717
Feb 202324310
Mar 20234020
Apr 202326110
May 20232229
Jun 20231766
Jul 20231006
Aug 202324147
Sep 20232976
Oct 20231604
Nov 202331132
Dec 20232113
Jan 20241823
Feb 20242214
Mar 20243284
Apr 20241813
May 20242313
Jun 20241546
Jul 20242026
Aug 202428310
Sep 20242078
Oct 202418210
Nov 20241218
Back to top
Posted May 02, 2020.
Download PDF
Data/Code
Email
Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease: A retrospective study
Jihad Mallat, Fadi Hamed, Maher Balkis, Mohamed A. Mohamed, Mohamad Mooty, Asim Malik, Ahmad Nusair, Maria-Fernanda Bonilla
medRxiv 2020.04.27.20082180; doi: https://doi.org/10.1101/2020.04.27.20082180
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area